Assessment of right ventricular functions during cancer chemotherapy

European Journal of Echocardiography

Volumn 12, Issue 11, 2011, Pages 834-840

  Tanindi, Asli ^a   Demirci, Umut ^a   Tacoy, Gulten ^a   Buyukberber, Suleyman ^a   Alsancak, Yakup ^a   Coskun, Ugur ^a   Yalcin, Ridvan ^a   Benekli, Mustafa ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Chemotherapy; N terminal pro brain natriuretic peptide Introdu; Right ventricular function; Tissue Doppler echocardiography; Tricuspid annular plane systolic excursion

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; HEART RIGHT VENTRICLE FUNCTION; HUMAN; PRIORITY JOURNAL; TRICUSPID VALVE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84856366003     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jer142     Document Type: Article

References (42)

1. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS et al. ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 2007;25:3991-4008. (Pubitemid 47477279)
2. Patel CD, Balakrishnan VB, Kumar L, Naswa N, Malhotra A. Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity? Hell J Nucl Med 2010;13:233-7.
3. Jassal DS, Han SY, Hans C, Sharma A, Fang T, Ahmadie R et al. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. J Am Soc Echocardiogr 2009;22:418-24.
4. Lotrionte M, Palazzoni G, Natali R, Comerci G, Abbate A, Loperfido F et al. Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy. Minerva Cardioangiol 2007;55:711-20. (Pubitemid 351169834)
5. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001;37:183-8. (Pubitemid 32051736)
6. Dell'Italia LJ. The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 1991;16:653-720.
7. Burgess MI, Bright-Thomas RJ, Ray SG. Echocardiographic evaluation of right ventricular function. Eur J Echocardiogr 2002;3:252-62. (Pubitemid 35345602)
8. Mavinkurve-Groothuis AM, Groot-Loonen J, Bellersen L, Pourier MS, Feuth T, Bökkerink JP et al. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines. Pediatr Blood Cancer 2009; 52:631-6.
9. Mavinkurve-Groothuis AM, Kapusta L, Nir A, Groot-Loonen J. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature. Pediatr Hematol Oncol 2008;25:655-64.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
11. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
12. López-Candales A, Rajagopalan N, Gulyasy B, Edelman K, Bazaz R. Comparative echocardiographic analysis of mitral and tricuspid annular motion: differences explained with proposed anatomic-structural correlates. Echocardiography 2007; 24:353-9. (Pubitemid 46449753)
13. Schiller NB. Pulmonary artery pressure estimation by Doppler and twodimensional echocardiography. Cardiol Clin 1990;8:277-87. (Pubitemid 20292988)
14. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol 1987;9:549-54. (Pubitemid 17024576)
15. López-Candales A, Bazaz R, Edelman K, Gulyasy B. Apical systolic eccentricity index: a better marker of right ventricular compromise in pulmonary hypertension. Echocardiography 2010;27:534-8.
16. Dokainish H, Abbey H, Gin K, Ramanathan K, Lee PK, Jue J. Usefulness of tissue Doppler imaging in the diagnosis and prognosis of acute right ventricular infarction with inferior wall acute left ventricular infarction. Am J Cardiol 2005;95: 1039-42. (Pubitemid 40544304)
17. Nagy AC, Cserep Z, Tolnay E, Nagykalnai T, Forster T. Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective Tissue Doppler Imaging Study. Pathol Oncol Res 2008;14:69-77.
18. Mangina-Tassan S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 2006;7:141-6. (Pubitemid 43257199)
19. Nagy AC, Tolnay E, Nagykalnai T, Forster T. Cardiotoxicity of anthracycline inn young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI. Neoplasma 2006;53:511-7. (Pubitemid 46133513)
20. Shapiro R, Barsuk D, Segev L, Shimon-Paluch S, Berkenstadt H, Zippel DB et al. Pre-operative cardiac workup after anthracycline-based neoadjuvant chemotherapy. Is it really necessary? Ann R Coll Surg Engl 2011;93:127-9.
21. Yildirim A, Tunaoglu FS, P?narl? FG, Ilhan M, Oguz A, Karadeniz C et al. Tissue and flow myocardial performance index measurements taken during dobutamine stress echocardiography for early diagnosis of late anthracycline cardiotoxicity. Pediatr Cardiol 2010;31:96-105.
22. Karakurt C, Koçak G, Ozgen U. Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy. Echocardiography 2008;25:880.
23. Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 2009;158:294-301.
24. Jurcut R, Wildiers H, Ganame J, D'hooge J, De Backer J, Denys H et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 2008;21: 1283-89.
25. Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 2010;96:701-7.
26. Ganame J, Claus P, Eyskens B, Uyttebroeck A, Renard M, D'hooge J et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol 2007;99:974-7. (Pubitemid 46483288)
27. Corapçioglu F, Sarper N, Berk F, Sahin T, Zengin E, Demir H. Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography. Pediatr Hematol Oncol 2006;23:71-80. (Pubitemid 41769977)
28. Appel JM, Sogaard P, Mortensen CE, Skagen K, Nielsen DL. Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer. J Am Soc Echocardiogr 2011;24:200-6.
29. Robert J. Epirubicin. Clinical pharmacology and dose-effect relationship. Drugs 1993;45:20-30. (Pubitemid 23262205)
30. Mortensen SA, Olsen HS, Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J 1986;55:274-82. (Pubitemid 16137871)
31. Belham M, Kruger A, Pritchard C. The Tei index identifies a differential effect on left and right ventricular function with low-dose anthracycline chemotherapy. J Am Soc Echocardiogr 2006;19:206-10. (Pubitemid 43191934)
32. Cottin Y, Touzery C, Coudert B, Richebourg S, Cohen M, Toubeau M. Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of women. Eur J Nucl Med 1996;23:511-6. (Pubitemid 26140578)
33. Yildirim A, Sedef Tunaoglu F, Güçlü Pinarli F, Ilhan M, Oguz A, Karadeniz C et al. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion. Eur J Echocardiogr 2010;11:814-22.
34. Ueti OM, Camargo EE, Ueti Ade A, de Lima-Filho EC, Nogueira EA. Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion: comparison with radionuclide angiography. Heart 2002; 88:244-8. (Pubitemid 34913505)
35. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.
36. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66. (Pubitemid 26011184)
37. Dabestani A, Mahan G, Gardin JM, Takenaka K, Burn C, Allfie A et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987;59:662-8. (Pubitemid 17047340)
38. Lopez-Candales A, Eleswarapu A, Shaver J, Edelman K, Gulyasy B, Candales MD. Right ventricular outflow tract spectral signal: a useful marker of right ventricular systolic performance and pulmonary hypertension severity. Eur J Echocardiogr 2010;11:509-15.
39. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
40. Hinderliter AL, Willis PW 4th, Barst RJ, Rich S, Rubin LJ, Badesch DB et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 1997;95: 1479-86. (Pubitemid 27142806)
41. Wacker A, Lersch C, Scherpinski U, Reindl L, Seyfarth M. High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients. Oncology 2003;65:108-12. (Pubitemid 37025969)
42. Saif MW, Shah MM, Shah AR. Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf 2009;8:191-202.